Latest Update
July 2026 – Tentative Global Settlement Reported
The parties have reportedly reached a tentative global settlement of the Depo-Provera meningioma litigation, announced in June 2026 with terms not yet public, and a hearing previously set for June has been moved to July 27 in light of the announcement. The Daubert hearings on general causation were held June 24 to 26. More than 5,800 lawsuits are pending in MDL 3140 before Judge M. Casey Rodgers in the Northern District of Florida, and the FDA-approved label has warned about meningioma risk only since December 2025, meaning most women who used the shot were never warned.
Written by Fob James IV, Esq. | Fob James Law Firm, LLC | Birmingham, Alabama | Last Updated: July 16, 2026
Depo-Provera Lawsuit in Birmingham – July 2026 Status
- The claim: women diagnosed with meningioma brain tumors after Depo-Provera injections allege Pfizer failed to warn, and the FDA-approved label carried no meningioma warning until December 2025
- Where the cases are: MDL 3140 before Judge M. Casey Rodgers in the Northern District of Florida, more than 5,800 lawsuits pending as of July 2026
- The big news: a tentative global settlement was reportedly announced in June 2026, terms not yet public, with a hearing moved to July 27
- Birmingham: our office is here, and we represent women across the metro and Alabama
- Timing: with a settlement framework reportedly forming, get evaluated now, the consultation is free: (205) 407-6009
Many of the women who call us say Depo shot rather than Depo-Provera, and the questions are the same either way: whether a meningioma diagnosed after years of Depo shot injections qualifies, and, now that a settlement framework is reportedly taking shape, when any payout would actually reach the women who file. The honest answer on timing is that no payout date exists yet, because the settlement terms have not been finalized or made public, and being evaluated and on file now is how you position a claim to participate in whatever framework emerges.
⚖️ June 15, 2026 Update: Global Settlement Agreement Reached in the Depo-Provera MDL
On June 15, 2026, the parties in the Depo-Provera MDL (No. 3140) announced a global settlement agreement in principle. The terms and eligibility criteria have not yet been released, and the agreement is not expected to resolve every case.
In light of the settlement, the first bellwether trial (previously set for December 7, 2026) was placed on hold, and the Rule 702 (Daubert) causation hearing was rescheduled to July 27, 2026 in Pensacola. Filing now may be important to qualify under the settlement’s eligibility criteria. Call 205-407-6009 for a free review.
In short: Birmingham-area women diagnosed with a meningioma brain tumor after using Depo-Provera for a year or more may qualify to file a lawsuit. Cases are consolidated in federal MDL No. 3140 (5,500+ filings as of June 2026). Fob James Law Firm is a Birmingham firm — our office is minutes from UAB and the Jefferson County Courthouse — representing local women on a contingency fee (33–40%), no fee unless we win. Call 205-407-6009.
If you were diagnosed with a meningioma brain tumor after receiving Depo-Provera birth control shots in the Birmingham area, the Depo-Provera lawsuit lawyers at Fob James Law Firm can help. Our Birmingham office is located at 2226 1st Ave S, Suite 105, Birmingham, AL 35233, and we have been fighting for drug injury victims for over 40 years.
Depo-Provera — Pfizer’s injectable contraceptive — has been linked to a 5x or greater increase in the risk of meningioma brain tumors after prolonged use. More than 5,500 lawsuits have been filed in the federal MDL as of June 2026, including lawsuits by Birmingham-area women, and in June 2026 the parties reached a global settlement agreement in principle. If you or a loved one was diagnosed with a meningioma, call us today at 205-407-6009 for a free, confidential case evaluation.
Birmingham Depo-Provera Lawsuit Quick Facts
| Detail | Information |
|---|---|
| Drug | Depo-Provera (medroxyprogesterone acetate) by Pfizer |
| Injury | Meningioma brain tumors |
| Risk Increase | 5x+ after 1 year of use (BMJ, 2024) |
| MDL | No. 3140, N.D. Florida, Judge M. Casey Rodgers |
| Cases Filed | 5,500+ as of June 2026 |
| Settlement | Global agreement in principle reached June 15, 2026 (terms not yet public) |
| Daubert/Causation Hearing | July 27, 2026 (Pensacola) |
| First Trial Date | On hold — Dec. 7, 2026 deadlines vacated (June 2026 settlement) |
| Alabama Filing Deadline | 2 years (manufacturer) / 1 year (original seller) |
| Our Fees | 33–40% contingency — you pay nothing unless we win |
| Birmingham Office | 2226 1st Ave S, Suite 105, Birmingham, AL 35233 |
| Phone | 205-407-6009 |
Why Birmingham Women Choose Fob James Law Firm
Fob James Law Firm is not a national lead-generation operation or an out-of-state firm running ads in Birmingham. We are a Birmingham-based law firm that has served this community for decades. When you call our office, you speak with your attorney — not an intake center.
Here is why Birmingham women trust us with their Depo-Provera cases:
- We are in Birmingham. Our office is minutes from UAB, Grandview Medical Center, and the Jefferson County Courthouse. If you need to meet in person, we are here.
- You talk to your lawyer. Fob James IV personally handles client communications — not a paralegal or a case manager at a call center.
- Lower fees than most firms. We charge a 33–40% contingency fee, saving you thousands compared to the 45% many mass tort firms charge. You pay nothing unless we win.
- Deep pharmaceutical litigation experience. We handle defective drug and mass tort cases nationwide, backed by the resources of national co-counsel networks.
- We handle cases in all 50 states — but our home is Birmingham, Alabama.
See our case results and client testimonials.
Birmingham Women and the Depo-Provera Brain Tumor Risk
Thousands of women in the Birmingham metro area — including Jefferson County, Shelby County, and surrounding communities like Hoover, Vestavia Hills, Mountain Brook, Homewood, Trussville, and Bessemer — have received Depo-Provera shots from OB-GYNs, family physicians, community health clinics, and pharmacies over the past three decades.
Many of these women had no idea that the birth control shot they trusted could increase their risk of developing a meningioma brain tumor. The FDA did not require a meningioma warning on the Depo-Provera label until December 2025 — decades after the first scientific evidence suggested a link, and years after Canada and European countries had already mandated warnings.
For Birmingham women who have been diagnosed with a meningioma, the path forward often involves treatment at one of the area’s leading neurosurgical centers, including:
- UAB Medicine — home to one of the Southeast’s leading neurosurgery programs
- Alabama Neurological Surgery & Spine — located in Birmingham at 3535 Grandview Parkway
- Neurosurgical Associates, P.C. — with offices at St. Vincent’s Birmingham and in Hoover and Trussville
- Birmingham Neurosurgery & Spine Group
The cost of meningioma treatment — brain surgery, radiation, imaging, rehabilitation, and ongoing monitoring — can be devastating. A Depo-Provera lawsuit can help Birmingham families recover compensation for these expenses and hold Pfizer accountable.
Who Qualifies for the Depo-Provera Lawsuit in Birmingham?
You may qualify for the Depo-Provera lawsuit if you meet the following criteria:
- You received Depo-Provera, Depo-SubQ Provera, or a generic medroxyprogesterone acetate injection from a healthcare provider in Birmingham or anywhere else.
- You used the birth control shot for at least one to two years.
- You were diagnosed with a meningioma brain tumor (confirmed by MRI or CT scan) after starting Depo-Provera use.
It does not matter when you last received the shot. Many women who used Depo-Provera years or even decades ago are filing lawsuits today. The discovery rule may extend your filing deadline if you only recently learned about the connection between Depo-Provera and brain tumors.
Key evidence our attorneys will help you gather:
- Medical records documenting Depo-Provera injections (from your doctor, clinic, or pharmacy)
- Insurance billing records showing the birth control shot
- MRI or CT imaging confirming your meningioma diagnosis
- Treatment records (surgery, radiation, medications, rehabilitation)
To find out if you qualify, call 205-407-6009 or submit a free case review online.
The Science: Does Depo-Provera Cause Brain Tumors?
Yes — multiple peer-reviewed studies have established a significant link between Depo-Provera and meningioma brain tumors:
- BMJ (March 2024): Women who used Depo-Provera for more than one year were 5.6 times more likely to develop a meningioma. Study of 18,000+ women. (Source)
- JAMA Neurology (September 2025): Found a 2.43-fold risk increase among Depo-Provera users in a study of approximately 10 million women. (Source)
- University of British Columbia (February 2025): Found a 3.55x increased risk of meningioma after one year of use. (Source)
- Expert Opinion on Drug Safety (August 2025): Found a 3.5-fold increased risk compared to oral birth control pills.
In December 2025, the FDA approved a new Depo-Provera label that warns about the risk of meningioma brain tumors — the first time the U.S. label has acknowledged this risk.
For a detailed analysis of the scientific evidence and all four studies, see our main Depo-Provera Lawsuit page for Alabama.
Alabama Filing Deadlines for Birmingham Residents
Alabama has strict deadlines for product liability claims. In Depo-Provera cases:
- Two years from the date of injury for claims against the manufacturer (Pfizer and other drug companies).
- One year from the date of injury for claims against the original seller (the pharmacy, clinic, or healthcare provider who administered the shot) under the Alabama Extended Manufacturer’s Liability Doctrine (AEMLD), Ala. Code § 6-5-501 et seq.
The discovery rule is critical in Depo-Provera cases. Many women did not know — and could not reasonably have known — that their meningioma was connected to the birth control shot until the scientific evidence and media coverage emerged in 2024 and 2025. Alabama courts recognize that the statute of limitations does not begin to run until the plaintiff discovers or reasonably should discover both the injury and its cause.
Do not wait to file. Even if you used Depo-Provera years ago, you may still have time. But filing deadlines are strict, and the sooner you contact an attorney, the better we can protect your rights. Call 205-407-6009 today.
What Is a Depo-Provera Case Worth?
In June 2026, the parties reached a global settlement agreement in principle (terms and eligibility not yet public). The first bellwether trial, previously set for December 7, 2026, was placed on hold. Based on the severity of meningioma injuries and comparable pharmaceutical litigation, we estimate that most cases will settle in the $200,000 to $500,000+ range, with the most severe cases (multiple surgeries, permanent disability, death) potentially commanding significantly higher values. Prior results do not guarantee a similar outcome.
Damages in a Birmingham Depo-Provera case may include:
- Past and future medical bills (brain surgery, radiation, MRIs, rehabilitation, medications)
- Lost wages and loss of earning capacity
- Pain and suffering
- Emotional distress
- Loss of consortium (for spouses)
- Funeral and burial expenses (in wrongful death cases)
For a more detailed analysis of settlement estimates, see our Depo-Provera Lawsuit page for Alabama.
Birmingham Depo-Provera Lawsuit FAQ
How do I join the Depo-Provera lawsuit from Birmingham?
Call us at 205-407-6009 or contact us online. Our attorneys will review your medical history, help you gather records, and file your claim. The process is straightforward, and you can get started with a free phone consultation from our Birmingham office.
Is there a Depo-Provera class action?
The Depo-Provera litigation is a multidistrict litigation (MDL), not a class action. Each plaintiff files an individual lawsuit, but all cases are consolidated before Judge M. Casey Rodgers in the Northern District of Florida for pretrial proceedings. This means your case is evaluated individually, and your compensation depends on the specific facts of your situation. As of June 2026, more than 5,500 lawsuits are pending in the MDL.
Can I still file a Depo-Provera lawsuit in 2026?
Yes. New cases are being filed every month. Following a June 2026 settlement agreement in principle, the first bellwether trial was placed on hold and the Rule 702 (Daubert) causation hearing was rescheduled to July 27, 2026 in Pensacola. Alabama has strict filing deadlines, so you should contact an attorney promptly — and filing now may be important to qualify under the settlement’s eligibility criteria.
What does it cost to hire a Depo-Provera lawyer?
Nothing upfront. Fob James Law Firm handles all Depo-Provera cases on a contingency-fee basis — we only get paid if we win or settle your case. Our fee is 33–40% of the recovery, which is lower than the 45% many other mass tort firms charge.
When will Depo-Provera lawsuits be settled?
On June 15, 2026, the parties announced a global settlement agreement in principle. The terms and eligibility criteria have not yet been released, and it will not resolve every case. The first bellwether trial (previously set for December 7, 2026) was placed on hold, and the Rule 702 (Daubert) causation hearing was rescheduled to July 27, 2026 in Pensacola. Full resolution is expected to take approximately 1–2 years, depending on the settlement’s terms and the court’s approval process.
Where are the Depo-Provera lawsuits being handled?
The federal cases are consolidated in MDL No. 3140 in the Northern District of Florida under Judge M. Casey Rodgers. Depo-Provera lawsuits originally filed in the Northern District of Alabama (Birmingham’s federal court) transfer to the MDL for pretrial proceedings but will return to Alabama for trial if not resolved globally.
Latest Depo-Provera Litigation Updates
The Depo-Provera MDL is moving fast. Here are the latest developments as of June 2026:
- June 15, 2026: The parties announced a global settlement agreement in principle. The first bellwether trial (Dec. 7, 2026) was placed on hold, and the Daubert/Rule 702 causation hearing was rescheduled to July 27, 2026 in Pensacola. Terms and eligibility have not been released.
- June 11, 2026: The MDL surpassed 5,500 cases, growing at roughly 650 new filings per month.
- May 15, 2026: The Daubert hearing was continued (from May 26–28 to June 24–26) to allow expert briefing to finish; the case count climbed past 3,500.
- April 2, 2026: Discovery wrapping up; the Court signals its intent to hold the litigation to an aggressive schedule.
- March 6, 2026: Case Management Conference (rescheduled from February 20).
- February 5, 2026: Pfizer filed a supplemental preemption brief addressing the December 2025 FDA label change.
- January 27, 2026: Pretrial Order No. 30 confirms rulings on preemption and Daubert will apply MDL-wide.
- January 20, 2026: First bellwether trial date set for December 7, 2026 (later placed on hold).
- December 17, 2025: FDA approved a meningioma brain tumor warning on the Depo-Provera label.
For the full litigation timeline with detailed analysis of every major development, visit our Depo-Provera Lawsuit page for Alabama.
Contact Our Birmingham Depo-Provera Lawyers Today
If you or a loved one was diagnosed with a meningioma brain tumor after using Depo-Provera, the attorneys at Fob James Law Firm are ready to fight for you. We offer free, confidential consultations and charge no fees unless we win your case.
Fob James Law Firm, LLC 2226 1st Ave S, Suite 105 Birmingham, AL 35233
Phone: 205-407-6009 Toll Free: 866-837-1010
Schedule a Free Case Evaluation
We serve Depo-Provera clients throughout the greater Birmingham area, including Hoover, Vestavia Hills, Mountain Brook, Homewood, Trussville, Bessemer, Alabaster, Pelham, Helena, Gardendale, Fultondale, Center Point, Irondale, and all of Jefferson and Shelby Counties.